TARA Biosystems

📍 NEW YORK, United States🗓 Founded 2014👥 22 employees💰 Last funded Apr 2019
TARA is dedicated to pioneering predictive cardiac tissue models that enable faster, safer, and more reliable development of new medicines. Safer and more effective new medicines that rapidly make it to market means better health and longer life, and we believe that’s great for people everywhere. TARA is focused on three critical areas. Cardiac Toxicology: TARA’s predictive tissue-based cardiac model behaves like a human heart muscle. This means that when it is employed in drug testing it can reliably identify cardiovascular complications where cell culture and animal testing models cannot; leading to a faster, safer, and less costly development process. Precision Cardiology: Every person is different and each person’s biology contains information particular only to them. TARA's platform can be used to create custom cardiac models tailored to a single person, allowing for personalized health and treatment. Heart Failure Drug Discovery: Heart failure remains a leading cause of death throughout the world. TARA's platform generates physiologically accurate diseased human tissue from stem cells; allowing for reliable testing of medicines created to treat specific heart conditions. Visit us http://tarabiosystems.com or contact us at info@tarabiosystems.com!
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2014
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in TARA Biosystems?
TARA Biosystems has 2 investors on record on gritt.io, 2 mid-stage.
When did TARA Biosystems last raise funding?
The most recent investment in TARA Biosystems recorded on gritt.io was in April 2019.
When was TARA Biosystems founded?
TARA Biosystems was founded in 2014.
What industry is TARA Biosystems in?
TARA Biosystems operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is TARA Biosystems based?
TARA Biosystems is headquartered in NEW YORK, United States.